Pete Davidson Finasteride Guide: Everything You Need to Know About the Celebrity Hair Debate
Every systemic pharmaceutical requires an honest evaluation of risks. Finasteride is generally well tolerated, but patient hesitations are driven by legitimate physiological concerns. In double-blind clinical trials, adverse sexual side effects, including erectile dysfunction, decreased libido, and ejaculatory volume changes, occurred in 1.5% to 3.8% of men taking 1 mg daily, compared to 1.0% to 2.1% of men taking a placebo.
For most men who experience these symptoms, effects resolve after discontinuing the drug. A minority of users report persistent sexual, cognitive, or mood symptoms after cessation, a contentious condition referred to as post-finasteride syndrome (PFS). While regulatory agencies such as the FDA require warnings on packaging, medical consensus continues to research the psychological and neurosteroid mechanisms at play.
Physicians emphasize baseline diagnostics before initiating therapy. Measuring total and free testosterone, estradiol, dihydrotestosterone, and prostate-specific antigen (PSA) provides a clear benchmark. Finasteride reduces serum PSA levels by approximately 50% in adult men, an adjustment clinicians must account for when screening for prostate health.